A. Barrera

发表

Factors Affecting the Decision of Breast Cancer Patients to Undergo Contralateral Prophylactic Mastectomy

H. Kuerer, G. Babiera, K. Hunt, 2010, Cancer Prevention Research.

Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.

W. Woodward, G. Hortobagyi, V. Valero, 2017, The Lancet. Oncology.

Breast Tumors Maintain a Reservoir of Subclonal Diversity During Expansion

Thomas O. McDonald, Michael D. Nicholson, N. Navin, 2021, Nature.

Prospective Evaluation of Universal BRCA Testing for Women With Triple-Negative Breast Cancer

B. Arun, K. Lu, K. I. Muse, 2020, JNCI cancer spectrum.

Simplifying clinical use of the genetic risk prediction model BRCAPRO

Giovanni Parmigiani, Jonathan Chipman, Christopher I. Amos, 2013, Breast Cancer Research and Treatment.

Tissue Transglutaminase 2 as a Predictive and Prognostic Factor: A Pilot Study of Neoadjuvant Therapy in Women with Breast Cancer

Kapil, Diane D. Liu, K. Hunt, 2017 .

Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO

Giovanni Parmigiani, Amanda Blackford, Christopher I. Amos, 2012, Breast Cancer Research and Treatment.

Evaluation of BRCAPRO Risk Assessment Model in Patients with Ductal Carcinoma In situ Who Underwent Clinical BRCA Genetic Testing

H. Kuerer, B. Arun, K. I. Muse, 2016, Front. Genet..

Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer

K. Hunt, K. Do, M. Yi, 2019, Annals of surgery.

Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative

H. Kuerer, D. Tripathy, B. Arun, 2015, Journal of Cancer.

Breast radiotherapy-related treatment outcomes in patients with or without germline mutations on multigene panel testing.

Diane D. Liu, W. Woodward, Benjamin D. Smith, 2021, International journal of radiation oncology, biology, physics.